337 related articles for article (PubMed ID: 34903162)
1. Type III CRISPR-Cas Systems: Deciphering the Most Complex Prokaryotic Immune System.
Kolesnik MV; Fedorova I; Karneyeva KA; Artamonova DN; Severinov KV
Biochemistry (Mosc); 2021 Oct; 86(10):1301-1314. PubMed ID: 34903162
[TBL] [Abstract][Full Text] [Related]
2. Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.
Liu TY; Doudna JA
J Biol Chem; 2020 Oct; 295(42):14473-14487. PubMed ID: 32817336
[TBL] [Abstract][Full Text] [Related]
3. The abortive infection functions of CRISPR-Cas and Argonaute.
Chen Y; Zeng Z; She Q; Han W
Trends Microbiol; 2023 Apr; 31(4):405-418. PubMed ID: 36463018
[TBL] [Abstract][Full Text] [Related]
4. Origins and evolution of CRISPR-Cas systems.
Koonin EV; Makarova KS
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180087. PubMed ID: 30905284
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-based technologies: prokaryotic defense weapons repurposed.
Terns RM; Terns MP
Trends Genet; 2014 Mar; 30(3):111-8. PubMed ID: 24555991
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas immunity in prokaryotes.
Marraffini LA
Nature; 2015 Oct; 526(7571):55-61. PubMed ID: 26432244
[TBL] [Abstract][Full Text] [Related]
7. Type III CRISPR-Cas: beyond the Cas10 effector complex.
Stella G; Marraffini L
Trends Biochem Sci; 2024 Jan; 49(1):28-37. PubMed ID: 37949766
[TBL] [Abstract][Full Text] [Related]
8. Diverse CRISPR-Cas Complexes Require Independent Translation of Small and Large Subunits from a Single Gene.
McBride TM; Schwartz EA; Kumar A; Taylor DW; Fineran PC; Fagerlund RD
Mol Cell; 2020 Dec; 80(6):971-979.e7. PubMed ID: 33248026
[TBL] [Abstract][Full Text] [Related]
9. Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence.
Grüschow S; Athukoralage JS; Graham S; Hoogeboom T; White MF
Nucleic Acids Res; 2019 Sep; 47(17):9259-9270. PubMed ID: 31392987
[TBL] [Abstract][Full Text] [Related]
10. Characterization and applications of Type I CRISPR-Cas systems.
Hidalgo-Cantabrana C; Barrangou R
Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
[TBL] [Abstract][Full Text] [Related]
11. CoCoNuTs are a diverse subclass of Type IV restriction systems predicted to target RNA.
Bell RT; Sahakyan H; Makarova KS; Wolf YI; Koonin EV
Elife; 2024 May; 13():. PubMed ID: 38739430
[TBL] [Abstract][Full Text] [Related]
12. DNA targeting by subtype I-D CRISPR-Cas shows type I and type III features.
Lin J; Fuglsang A; Kjeldsen AL; Sun K; Bhoobalan-Chitty Y; Peng X
Nucleic Acids Res; 2020 Oct; 48(18):10470-10478. PubMed ID: 32960267
[TBL] [Abstract][Full Text] [Related]
13. The immune system of prokaryotes: potential applications and implications for gene editing.
Liu S; Liu H; Wang X; Shi L
Biotechnol J; 2024 Feb; 19(2):e2300352. PubMed ID: 38403433
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.
Wang L; Mo CY; Wasserman MR; Rostøl JT; Marraffini LA; Liu S
Mol Cell; 2019 Jan; 73(2):278-290.e4. PubMed ID: 30503774
[TBL] [Abstract][Full Text] [Related]
15. The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems.
Foster K; Kalter J; Woodside W; Terns RM; Terns MP
RNA Biol; 2019 Apr; 16(4):449-460. PubMed ID: 29995577
[TBL] [Abstract][Full Text] [Related]
16. Diversity of CRISPR-Cas-Mediated Mechanisms of Adaptive Immunity in Prokaryotes and Their Application in Biotechnology.
Savitskaya EE; Musharova OS; Severinov KV
Biochemistry (Mosc); 2016 Jul; 81(7):653-61. PubMed ID: 27449612
[TBL] [Abstract][Full Text] [Related]
17. Interference Requirements of Type III CRISPR-Cas Systems from Thermus thermophilus.
Karneyeva K; Kolesnik M; Livenskyi A; Zgoda V; Zubarev V; Trofimova A; Artamonova D; Ispolatov Y; Severinov K
J Mol Biol; 2024 Mar; 436(6):168448. PubMed ID: 38266982
[TBL] [Abstract][Full Text] [Related]
18. The RNA- and DNA-targeting CRISPR-Cas immune systems of Pyrococcus furiosus.
Terns RM; Terns MP
Biochem Soc Trans; 2013 Dec; 41(6):1416-21. PubMed ID: 24256230
[TBL] [Abstract][Full Text] [Related]
19. Casposons: a new superfamily of self-synthesizing DNA transposons at the origin of prokaryotic CRISPR-Cas immunity.
Krupovic M; Makarova KS; Forterre P; Prangishvili D; Koonin EV
BMC Biol; 2014 May; 12():36. PubMed ID: 24884953
[TBL] [Abstract][Full Text] [Related]
20. Progress of CRISPR-based programmable RNA manipulation and detection.
Wang B; Yang H
Wiley Interdiscip Rev RNA; 2023; 14(6):e1804. PubMed ID: 37282821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
